跳至主要内容
临床试验/DRKS00031072
DRKS00031072招募中不适用

Retrospective evaluation of interventional treatment of peripheral slow-flow malformations using image-guided bleomycin electrotherapy. - BEST

MU München0 个研究点目标入组 300 人开始时间: 2023年2月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • Patients with a diagnosis of combined slow-flow peripheral vascular malformation (capillary-venous malformation, CVM; capillary-lymphatic malformation, CLM; lymphatic-venous malformation, LVM; capillary-lymphatic-venous malformation, CLVM) and who have undergone imaging-guided treatment by a Bleomycin electro-sclerotherapy (BEST) in the form of one or more sessions in the period from 01.01.2020 to 30.12.2022

排除标准

  • Patients with other vascular anomalies (high-flow malformations) or vascular tumors
  • Patients who have received the above procedures with other image-guided sclerotherapy/embolization techniques, e.g. B. Polidocanol sclerotherapy

研究者

发起方
MU München

相似试验